QCG
NBP

Quadrant Capital Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Quadrant Capital Group’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-51
Closed -$1K – 2627
2022
Q1 		$1K Buy
51
+31
+155% +$794 ﹤0.01% 2317
2021
Q4 		$1K Buy
20
+5
+33% +$300 ﹤0.01% 2317
2021
Q3 		$1K Buy
+15
New +$1.08K ﹤0.01% 2321

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quadrant Capital Group's NBP Position: Q2 2022 in Review

Quadrant Capital Group sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2022, closing a stake of 51 shares — an estimated $1K sold.

Quadrant Capital Group first reported a position in NBP in Q3 2021 and held it in 3 quarters. The position peaked at $1K in Q1 2022. 97 funds tracked by Wall St. Rank hold NBP as of Q2 2022.

  • Quadrant Capital Group reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • Quadrant Capital Group sold 51 NovaBridge Biosciences American Depositary Shares shares in Q2 2022, an estimated $1K.
  • Quadrant Capital Group first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2021 and held it in 3 quarters.
  • Quadrant Capital Group's NovaBridge Biosciences American Depositary Shares position peaked at $1K in Q1 2022.
  • 97 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2022.

Based on Quadrant Capital Group's 13F filing for Q2 2022, filed 9 Aug 2022.